Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients

NCT00103610 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

298

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG: Granulocyte colony-stimulating factor plus plerixafor
DRUG: Granulocyte colony-stimulating factor plus placebo

Sponsor

Genzyme, a Sanofi Company